Bayer applies for EU approval of menopause drug elinzanetant

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.

Oct 16, 2024 - 04:00

Bayer applies for EU approval of menopause drug elinzanetant

Bayer notches up pressure on rival Astellas’ Veozah with an EU marketing authorisation application for its hot flash relief pill.

Read the original article

Tags:

Previous Article

Lilly touts Omvoh’s superiority over J&J’s Stelara in Crohn’s

Transgene’s stock drops after Phase II cancer jab trial misses primary endpoint

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Vicebio secures $100m to advance RSV and hMPV vaccine combo to Phase I

Vicebio secures $100m to advance RSV and hMPV vaccine c...

Sep 24, 2024

Opinion: Listen: The true costs of mediocre insurance plans for medical students

Opinion: Listen: The true costs of mediocre insurance p...

Nov 15, 2023

Labcorp forms spin-off of Fortrea

Labcorp forms spin-off of Fortrea

Jul 5, 2023